News

Publication - Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic

Abstract - The magnitude of the 2013-2016 Ebola virus disease (EVD) epidemic enabled an unprecedented number of viral mutations to occur over successive human-to-human transmission events, increasing the probability that adaptation to the human host occurred during the outbreak.

Press - "I Don't Know if I'm Already Infected"

He was a globally renowned expert in tropical diseases, and the hero who ran Sierra Leone’s worst Ebola ward. So why, when he finally fell ill, was he denied the extraordinary treatments that could have saved him?

Publication - Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Abstract - Lassa fever is a significant health threat to West African human populations with hundreds of thousands of annual cases. There are no approved medical countermeasures currently available. Compassionate use of the antiviral drug ribavirin or transfusion of convalescent serum has resulted in mixed success depending on when administered or the donor source, respectively.

Zalgen Labs Introduces Viral Diagnostics Business

Opens Advanced Product Development Center in Colorado

Publication - Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection

Background - The 2013-2016 West African Ebola virus disease (EVD) epidemic is the largest recorded. Triage on the basis of clinical signs had limited success, and the time to diagnosis by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) could exceed 5 days.

Publication - VHFC Researchers from West Africa Publish Essential Insights into Ebola Outbreak Response

In two separate articles published in The Journal of Infectious Diseases, VHFC researchers from Nigeria and Sierra Leone provide key insights into the Ebola outbreak response that took place during the 2013-2016 Ebola epidemic.

Publication - Roots, Not Parachutes

The recent outbreaks of Ebola and Zika virus have highlighted how health system failures in seemingly geographically remote areas can result in disease vulnerabilities across the globe.

Dr. Kristian Andersen named 2016 Pew Scholar in the Biomedical Sciences

Program provides funding to young investigators of outstanding promise

Publication - New Lassa fever study published in Nature Communications

Abstract

VHFC Physician Graduates Top of His Class

The Viral Hemorrhagic Fever Consortium is delighted to announce that Dr. Donald S. Grant, Chief Physician of the Lassa Fever Program at Kenema Government Hospital in Sierra Leone, has obtained a Master of Science in Public Health degree from the Tulane School of Public Health and Tropical Medicine. Dr.

Syndicate content
PSD to Drupal theme